Steven J. Jacobsen, MD, PhD
- Education and Training
BS, summa cum laude, University of Wisconsin-Whitewater
Graduate Fellowship Recipient, University of Illinois at Chicago
MS, Medical College of Wisconsin
PhD, University of Illinois at Chicago
MD, Medical College of Wisconsin
Dr. Steven Jacobsen directs the research programs for the Kaiser Permanente Southern California region and the Department of Research and Evaluation, with over 30 faculty in epidemiology, health services, and related research. He serves as Principal Investigator for the CDC-funded Vaccine Safety Datalink and has directed several large-scale, FDA-mandated, post-licensure safety studies. Prior to joining Kaiser Permanente, he was Professor and Chair of the Division of Epidemiology in the Mayo Clinic College of Medicine. Dr. Jacobsen is a chronic disease epidemiologist with a longstanding interest in men’s urological health, cardiovascular disease, and vaccine research. He has a long track record of extramurally funded research and has authored or co-authored more than 500 papers in the peer-reviewed literature. He currently serves on four editorial boards for peer-reviewed journals, and has served on numerous NIH study sections and advisory panels.
- Prior Positions (selected)
- 1993-2001Head, Section of Clinical EpidemiologyMayo Clinic1992-1995Assistant Professor of EpidemiologyMayo Clinic School of Medicine1993-2006Consultant in EpidemiologyMayo Clinic1995-1999Associate Professor of EpidemiologyMayo Clinic School of Medicine1999-2006Professor of EpidemiologyMayo Clinic School of Medicine2002-2006Chair, Division of EpidemiologyMayo Clinic2006-presentDirector of ResearchSouthern California Permanente Medical Group2009-2011Research ProfessorUniversity of Southern California
- Honors and Awards (selected)
- 1986Thomas Hale Ham Award for New Investigator, Research in Medical EducationAssociation of American Medical Colleges1997Elected FellowAmerican College of Epidemiology1998Elected MemberAmerican Epidemiological Society2005Best AbstractFirst International Conference on Urogenital Disorders, from Gene to Clinics2013Dr. Jacob Brody Distinguished Alumni Awardversity of Illinois at Chicago School of Public Health Alumni Association2013American Journal of Epidemiology Article of the YearAdapting Group Sequential Methods to Observational Postlicensure Vaccine Safety Surveillance: Results of a Pentavalent Combination DTaP-IPV-Bib Vaccine Safety Study
- Publications (selected)
Peer-reviewed research manuscripts (selected)
Tartof SY, Qian L, Rieg GK, Yu KC, Sy LS, Tseng HF, Hechter RC, Jacobsen SJ. Safety of seasonal influenza vaccination in hospitalized surgical patients: a cohort study. Ann Intern Med. 2016;164:593-599.
Reading SR, Porter KR, Hsu JY, Wallner LP, Loo RK, Jacobsen SJ. Racial and ethnic variation in time to prostate biopsy after an elevated screening level of serum prostate-specific antigen. Urology. 2016;96:121-127.
Tseng HF, Sy LS, Ackerson BK, Hechter RC, Tartof SY, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Cunnington M, Solano Z, Jacobsen SJ. Safety of quadrivalent meningococcal conjugate vaccine in 11- to 21-Year-Olds. Pediatrics. 2017;139.
Ackerson B, Hechter R, Sidell M, Sy LS, Slezak J, Chao C, Patel N, Tseng HF, Jacobsen S. Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017;35:897-902.
Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D’Agostino R Jr, Loo RK, Aaronson DS, Horwitz R, Jacobsen SJ. The use of 5-alpha reductase inhibitors to manage benign prostatic hyperplasia and the risk of all-cause mortality. Urology. 2018. Epub.
Sim JJ, Zhou H, Bhandari S, Wei R, Brettler JW, Tran-Nguyen J, Handler J, Shimbo D, Jacobsen SJ, Reynolds K. Low Systolic blood pressure from treatment and association with serious falls/syncope. Am J Prev Med. 2018. Epub.